SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-060963
Filing Date
2014-02-20
Accepted
2014-02-20 17:28:36
Documents
4
Group Members
ALEX ZISSONERIC AGUIARJAMES THOMASPETER MCNERNEYTHOMAS, MCNERNEY & PARTNERS II, LLCTMP ASSOCIATES II, L.P.TMP NOMINEE II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d677781dsc13d.htm SC 13D 182991
2 EX-99.B d677781dex99b.htm EX-99.B 12958
3 EX-99.C d677781dex99c.htm EX-99.C 15035
4 EX-99.D d677781dex99d.htm EX-99.D 3482
  Complete submission text file 0001193125-14-060963.txt   216210
Mailing Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402
Business Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402 612-456-8660
Thomas, McNerney & Partners II L.P. (Filed by) CIK: 0001369574 (see all company filings)

IRS No.: 721618589
Type: SC 13D

Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Subject) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87930 | Film No.: 14630750
SIC: 2834 Pharmaceutical Preparations